Updated with corrections.
BlackRock’s original date for its U.S. employees to return to work in its offices was in early September. Also, the firm has not announced whether COVID-19 vaccinations will be required for employees when they resume working in its U.S. offices on Oct. 1.
PIMCO will not require that its employees be vaccinated when they return to work in the firm’s offices in October.
Incorrect information was provided in an earlier version of this story that ran in the Aug. 19 P&I Daily.
Concern over the recent surge in COVID-19 and delta variant cases has convinced some money managers to delay the full opening of their U.S. offices.
Among firms that pushed their initial early fall U.S. return-to-office dates to October are BlackRock, Bridgewater Associates, Pacific Investment Management Co., Putnam Investment Management and T. Rowe Price Associates.
T. Rowe Price postponed its return to in-office work to Oct. 18 from Sept. 13, said a company spokesman in an email.
"We made this decision to help reduce the potential for continued community spread of the delta variant and to support a safer working environment," the spokesman said.
T. Rowe Price is not requiring that its employees be vaccinated against COVID-19 and variants but is "encouraging" that they receive the vaccine, he said.
T. Rowe Price managed $1.62 trillion as of June 30.
Putnam delayed the reopening of its U.S. offices in response to the continuing pandemic to Oct. 4 from Sept. 7, said spokeswoman Laura McNamara in an email.
Putnam has been "closely monitoring current public health developments, particularly the delta variant and (the) increase in the number of COVID-19 cases," she said.
All employees working in Putnam's U.S. offices must be vaccinated, Ms. McNamara said.
Putnam managed $200 billion as of July 31.